Peroxisome proliferator-activated receptor gamma mutation in familial partial lipodystrophy type three: A case report and review of literature

Table 1 Comparison of treatment regimens before and after the use of PPARG agonists

Before pioglitazone treatment	After pioglitazone treatment
Insulin glargine injection, 12 μL, QD	Pioglitazone, 30 mg, QD
Recombinant lispro insulin injection, 10 μL, TID	Dapagliflozin, 10 mg, QD
Fenofibrate, 200 mg, QD	Fenofibrate, 200 mg, QD
Irbesartan, 300 mg/day, QD	Irbesartan, 150 mg, QD
Levamlodipine besylate, 2.5 mg/day, QD

QD: Once daily; TID: Three times daily.